Abstract:Abstract Improved understanding and targeting of pathways involved in actinic keratoses (AK) could reduce the incidence of keratinocyte carcinoma. The objective of this study was to elucidate pathways involved in AK as potential therapeutic targets. In total, 443 AK samples were analysed after ethics approval was obtained. Nine transgenic mouse models were used to elucidate the biology of AK with approval. Analysis of 161 human AKs identified the presence of epidermal koilocytes in 70% of tissue samples (Table), indicating viral aetiology. The presence of koilocytes was more common in men (P < 0.05), but was not affected by age, site or type. Genotyping of AKs with koilocytes indicated the presence of human papillomavirus (HPV)8, with 100% sensitivity and 98% positive predictive value (P < 0.01). A triple cross HPV8tg:Lrig1CreERT2:R26RConfetti mouse model, in which HPV8 early region genes were expressed throughout the skin, led to epidermal changes of AK. Analysis of HPV8 mouse models determined these epidermal changes to be derived from a polyclonal expansion of hair follicle junctional zone, but not bulge, keratinocyte stem cells. A colony-forming assay confirmed that the epidermal keratinocytes retained the phenotype of keratinocyte stem cells (P < 0.01). Furthermore, this population had no melanin ‘cap’, suggesting increased susceptibility to ultraviolet mutagenesis. Comparison of HPV8 and wildtype mouse keratinocyte stem cell populations identified activation of the signal transducer and activator of transcription (STAT)3 pathway in the HPV8 mouse hair follicle junctional zone, suggesting this is involved in AK development. When evaluating human AK samples the STAT3 pathway is also activated. Blocking STAT3 (with siRNA) or its upstream signalling component Src kinase (with siRNA or tirbanibulin) prevented the epidermal changes of AK and subsequent tumorigenesis, suggesting that the STAT3 pathway is an important therapeutic target. In conclusion, understanding the pathogenesis of AK is critical for skin cancer prevention. These findings redefine the biological basis of AK, in which HPV8 viral reactivation drives proliferation of hair follicle keratinocyte stem cells to create AK without need for DNA mutations. This study identifies an essential targetable signalling pathway for future drug development. Grants were received from LEO Foundation and Almirall.All AK (n = 164)AK with koilocytes (n = 117)AK without koilocytes (n = 47)Age (years), mean (SD); range70 (10); 42–9071 (10); 42–9069 (10); 48–84Sex, n (%); male, female57 (46), 68 (54)45 (79), 39 (57)12 (21), 29 (43)Site, n (%) Head/neck101 (66)70 (65)31 (70) Torso12 (8)10 (9)2 (5) Arm28 (18)19 (18)9 (20) Leg11 (8)9 (8)2 (5)Pathology findings, n (%) Bowenoid15 (9)14 (12)1 (2) Acantholytic3 (2)2 (2)1 (2) Hyperkeratotic or hypertrophic lesion20 (12)18 (15)2 (4) Lichenoid infiltrate16 (10)8 (7)8 (17)Percentages are based on available data.

Role of asprosin and meteorin-like peptide in progression of actinic keratosis to squamous cell carcinoma

Dermoscopy and Reflectance Confocal Microscopy in Actinic Keratosis, Intraepithelial Carcinoma, and Invasive Squamous Cell Carcinoma

Gene Expression Patterns of Cutaneous Squamous Cell Carcinoma and Actinic Keratosis: Biomarkers Screening for Skin Disease Diagnosis

Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma

A Panel of Potential Serum Markers Related to Angiogenesis, Antioxidant Defense and Hypoxia for Differentiating Cutaneous Squamous Cell Carcinomas from Actinic Keratoses

Epidemiology and Risk Factors of Actinic Keratosis. What is New for The Management for Sun-Damaged Skin

The Genomic Landscape of Actinic Keratosis

Clinical Significance of Stat3 and Mapk Phosphorylation, and the Protein Expression of Cyclin D1 in Skin Squamous Cell Carcinoma Tissues

Identification of potential gene drivers of cutaneous squamous cell carcinoma: Analysis of microarray data

Prognostic Gene Signature for Squamous Cell Carcinoma with a Higher Risk for Treatment Failure and Accelerated MEK-ERK Pathway Activity

Advancements in elucidating the pathogenesis of actinic keratosis: present state and future prospects

Topical Treatment of Actinic Keratosis and Metalloproteinase Expression: A Clinico-Pathological Retrospective Study

Overexpression of Phosphorylated-Stat3 Correlated with the Invasion and Metastasis of Cutaneous Squamous Cell Carcinoma

Actinic keratosis metrics

The Significance of STAT3 and MAPK Phosphorylation and Cyclind1 Protein Expression in Skin Squamous Cell Carcinoma

Cystatin C Deficiency Promotes Epidermal Dysplasia in K14-HPV16 Transgenic Mice.

P039 Human papillomavirus 8-associated skin field cancerization demonstrates signal transducer and activator of transcription 3 pathway activation: a novel therapeutic target

The Loss of PPARγ Expression and Signaling Is a Key Feature of Cutaneous Actinic Disease and Squamous Cell Carcinoma: Association with Tumor Stromal Inflammation

Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression

The combined immunohistochemical expression of AMBRA1 and SQSTM1 identifies patients with poorly differentiated cutaneous squamous cell carcinoma at risk of metastasis: A proof of concept study